LNA Sante SA (LNA) - Net Assets
Based on the latest financial reports, LNA Sante SA (LNA) has net assets worth €328.27 Million EUR (≈ $383.79 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.57 Billion ≈ $1.84 Billion USD) and total liabilities (€1.25 Billion ≈ $1.46 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check LNA Sante SA (LNA) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €328.27 Million |
| % of Total Assets | 20.86% |
| Annual Growth Rate | 15.48% |
| 5-Year Change | 65.21% |
| 10-Year Change | 161.47% |
| Growth Volatility | 17.15 |
LNA Sante SA - Net Assets Trend (2004–2024)
This chart illustrates how LNA Sante SA's net assets have evolved over time, based on quarterly financial data. Also explore how large is LNA Sante SA's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for LNA Sante SA (2004–2024)
The table below shows the annual net assets of LNA Sante SA from 2004 to 2024. For live valuation and market cap data, see market value of LNA Sante SA.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €323.57 Million ≈ $378.28 Million |
+4.88% |
| 2023-12-31 | €308.52 Million ≈ $360.69 Million |
+3.26% |
| 2022-12-31 | €298.78 Million ≈ $349.31 Million |
+33.99% |
| 2021-12-31 | €222.99 Million ≈ $260.69 Million |
+13.85% |
| 2020-12-31 | €195.85 Million ≈ $228.97 Million |
-0.48% |
| 2019-12-31 | €196.80 Million ≈ $230.08 Million |
-3.68% |
| 2018-12-31 | €204.31 Million ≈ $238.86 Million |
+8.80% |
| 2017-12-31 | €187.79 Million ≈ $219.55 Million |
+14.72% |
| 2016-12-31 | €163.70 Million ≈ $191.38 Million |
+32.28% |
| 2015-12-31 | €123.75 Million ≈ $144.68 Million |
+17.79% |
| 2014-12-31 | €105.06 Million ≈ $122.83 Million |
+13.00% |
| 2013-12-31 | €92.97 Million ≈ $108.70 Million |
+8.54% |
| 2012-12-31 | €85.66 Million ≈ $100.14 Million |
+6.67% |
| 2011-12-31 | €80.30 Million ≈ $93.88 Million |
+11.32% |
| 2010-12-31 | €72.13 Million ≈ $84.33 Million |
+12.56% |
| 2009-12-31 | €64.08 Million ≈ $74.92 Million |
+25.07% |
| 2008-12-31 | €51.24 Million ≈ $59.90 Million |
+30.05% |
| 2007-12-31 | €39.40 Million ≈ $46.06 Million |
+10.29% |
| 2006-12-31 | €35.72 Million ≈ $41.76 Million |
+77.36% |
| 2005-12-31 | €20.14 Million ≈ $23.55 Million |
+10.70% |
| 2004-12-31 | €18.19 Million ≈ $21.27 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to LNA Sante SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 9787.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €192.80 Million | 61.44% |
| Common Stock | €21.42 Million | 6.83% |
| Other Comprehensive Income | €185.68 Million | 59.17% |
| Total Equity | €313.81 Million | 100.00% |
LNA Sante SA Competitors by Market Cap
The table below lists competitors of LNA Sante SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
HUA YU LIEN Development Co Ltd
TW:1436
|
$271.78 Million |
|
China General Plastics Corp
TW:1305
|
$271.85 Million |
|
Bonava AB (publ)
ST:BONAV-B
|
$271.87 Million |
|
Awfis Space Solutions Ltd
NSE:AWFIS
|
$271.89 Million |
|
Jikai Equipment Manufacturing Co Ltd
SHE:002691
|
$271.65 Million |
|
Stillfront Group AB (publ)
ST:SF
|
$271.64 Million |
|
KANGWON Co. Ltd
KQ:114190
|
$271.39 Million |
|
EBEST Investment & Securities Co. Ltd
KQ:078020
|
$271.26 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in LNA Sante SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 299,235,000 to 313,807,000, a change of 14,572,000 (4.9%).
- Net income of 21,815,000 contributed positively to equity growth.
- Dividend payments of 6,136,000 reduced retained earnings.
- Other comprehensive income increased equity by 16,260,000.
- Other factors decreased equity by 17,367,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €21.82 Million | +6.95% |
| Dividends Paid | €6.14 Million | -1.96% |
| Other Comprehensive Income | €16.26 Million | +5.18% |
| Other Changes | €-17.37 Million | -5.53% |
| Total Change | €- | 4.87% |
Book Value vs Market Value Analysis
This analysis compares LNA Sante SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.98x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 10.24x to 0.98x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | €2.81 | €28.80 | x |
| 2005-12-31 | €3.04 | €28.80 | x |
| 2006-12-31 | €4.97 | €28.80 | x |
| 2007-12-31 | €5.05 | €28.80 | x |
| 2008-12-31 | €6.41 | €28.80 | x |
| 2009-12-31 | €7.89 | €28.80 | x |
| 2010-12-31 | €8.40 | €28.80 | x |
| 2011-12-31 | €9.36 | €28.80 | x |
| 2012-12-31 | €10.06 | €28.80 | x |
| 2013-12-31 | €10.92 | €28.80 | x |
| 2014-12-31 | €11.72 | €28.80 | x |
| 2015-12-31 | €13.41 | €28.80 | x |
| 2016-12-31 | €17.48 | €28.80 | x |
| 2017-12-31 | €18.65 | €28.80 | x |
| 2018-12-31 | €20.37 | €28.80 | x |
| 2019-12-31 | €19.62 | €28.80 | x |
| 2020-12-31 | €19.69 | €28.80 | x |
| 2021-12-31 | €22.51 | €28.80 | x |
| 2022-12-31 | €27.93 | €28.80 | x |
| 2023-12-31 | €29.27 | €28.80 | x |
| 2024-12-31 | €29.30 | €28.80 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently LNA Sante SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.95%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.70%
- • Asset Turnover: 0.52x
- • Equity Multiplier: 4.90x
- Recent ROE (6.95%) is below the historical average (9.30%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 11.21% | 4.23% | 0.71x | 3.76x | €211.20K |
| 2005 | 7.43% | 2.11% | 0.98x | 3.60x | €-483.20K |
| 2006 | 6.75% | 3.16% | 0.67x | 3.18x | €-1.13 Million |
| 2007 | 8.92% | 2.85% | 0.66x | 4.78x | €-415.50K |
| 2008 | 9.87% | 3.14% | 0.67x | 4.69x | €-65.50K |
| 2009 | 9.73% | 3.07% | 0.80x | 3.95x | €-170.90K |
| 2010 | 11.49% | 4.00% | 0.77x | 3.74x | €1.07 Million |
| 2011 | 10.40% | 3.75% | 0.64x | 4.33x | €323.40K |
| 2012 | 7.30% | 2.40% | 0.61x | 4.97x | €-2.30 Million |
| 2013 | 8.33% | 2.38% | 0.65x | 5.42x | €-1.55 Million |
| 2014 | 7.04% | 1.97% | 0.61x | 5.85x | €-2.95 Million |
| 2015 | 8.98% | 2.50% | 0.67x | 5.34x | €-1.20 Million |
| 2016 | 13.71% | 4.55% | 0.71x | 4.24x | €5.85 Million |
| 2017 | 13.40% | 4.98% | 0.67x | 4.00x | €6.15 Million |
| 2018 | 10.93% | 4.00% | 0.75x | 3.67x | €1.82 Million |
| 2019 | 11.00% | 3.95% | 0.43x | 6.45x | €1.90 Million |
| 2020 | 4.14% | 1.36% | 0.38x | 7.94x | €-11.06 Million |
| 2021 | 10.88% | 3.41% | 0.45x | 7.08x | €1.90 Million |
| 2022 | 8.92% | 3.54% | 0.48x | 5.23x | €-3.12 Million |
| 2023 | 7.82% | 3.18% | 0.49x | 5.04x | €-6.51 Million |
| 2024 | 6.95% | 2.70% | 0.52x | 4.90x | €-9.57 Million |
Industry Comparison
This section compares LNA Sante SA's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $1,633,792,333
- Average return on equity (ROE) among peers: -5.61%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| LNA Sante SA (LNA) | €328.27 Million | 11.21% | 3.79x | $271.76 Million |
| Clariane SE (CLARI) | $1.90 Billion | 3.22% | 1.76x | $1.34 Billion |
| EMEIS SA (EMEIS) | $1.72 Billion | -23.93% | 6.79x | $2.24 Billion |
| Ramsay Generale De Sante (GDS) | $1.28 Billion | 3.87% | 4.45x | $1.18 Billion |
About LNA Sante SA
LNA Santé SA engages in the management and operation of healthcare facilities and medical residences for able-bodied, semi-dependent, or dependent elderly people in France. The company operates medical care and rehabilitation units; mental health clinics; health centres; and care homes. It also provides respiratory assistance and rehabilitation, cancerology, diabetology, pain management, therapeu… Read more